{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"AN2 Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"ANTX"},"Address":{"label":"Address","value":"1800 EL CAMINO REAL SUITE D, MENLO PARK, California, 94027, United States"},"Phone":{"label":"Phone","value":"+1 650 331-9090"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease."},"CompanyUrl":{"label":"Company Url","value":"https://www.an2therapeutics.com/"},"KeyExecutives":{"label":"Key Executives","value":[]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}